Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302 · see citing works

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · see citing works

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · see citing works

Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB

Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245 · see citing works

Protection from obesity-induced insulin resistance in mice lacking TNF-α function

Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234 · see citing works

Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance

Kern, P. A., Ranganathan, S., Li, C., Wood, L., & Ranganathan, G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e745 · Cited by 1,883 · see citing works

IKK-β links inflammation to obesity-induced insulin resistance

Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z.-W., Long, J. M., Wynshaw-Boris, A., Poli, G., Olefsky, J., & Karin, M. (2005) · Nature Medicine · doi:10.1038/nm1185 · Cited by 1,773 · see citing works

Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-κB Signaling Through a cAMP-Dependent Pathway

Ouchi, N., Kihara, S., Arita, Y., Okamoto, Y., Maeda, K., Kuriyama, H., Hotta, K., Nishida, M., Takahashi, M., Muraguchi, M., et al. (2000) · Circulation · doi:10.1161/01.cir.102.11.1296 · Cited by 1,730 · see citing works

Activation of interleukin-6 gene expression through the NF-kappa B transcription factor.

Libermann, T. A., & Baltimore, D. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.5.2327 · Cited by 1,372 · see citing works

Adipocyte-Derived Plasma Protein, Adiponectin, Suppresses Lipid Accumulation and Class A Scavenger Receptor Expression in Human Monocyte-Derived Macrophages

Ouchi, N., Kihara, S., Arita, Y., Nishida, M., Matsuyama, A., Okamoto, Y., Ishigami, M., Kuriyama, H., Kishida, K., Nishizawa, H., et al. (2001) · Circulation · doi:10.1161/01.cir.103.8.1057 · Cited by 1,275 · see citing works

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X

Pickup, J. C., Mattock, M. B., Chusney, G. D., & Burt, D. J. (1997) · Diabetologia · doi:10.1007/s001250050822 · Cited by 1,241 · see citing works

Elevated Levels of Acute-Phase Proteins and Plasminogen Activator Inhibitor-1 Predict the Development of Type 2 Diabetes

Festa, A., D’Agostino, R., Tracy, R. P., & Haffner, S. M. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1131 · Cited by 1,057 · see citing works

Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation

Tomas, E., Tsao, T.-S., Saha, A. K., Murrey, H. E., Zhang, C. C., Itani, S. I., Lodish, H. F., & Ruderman, N. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222657499 · Cited by 973 · see citing works

Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation

Chinetti, G., Fruchart, J.-C., & Staels, B. (2000) · Inflammation Research · doi:10.1007/s000110050622 · Cited by 954 · see citing works

Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis

Yamauchi, T., Kamon, J., Waki, H., Imai, Y., Shimozawa, N., Hioki, K., Uchida, S., Ito, Y., Takakuwa, K., Matsui, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209033200 · Cited by 911 · see citing works

Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B.

Collart, M. A., Baeuerle, P. A., & VASSALLI, P. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.4.1498 · Cited by 893 · see citing works

Interleukin-6 induces cellular insulin resistance in hepatocytes.

Senn, J. J., Klover, P. J., Nowak, I. A., & Mooney, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3391 · Cited by 883 · see citing works

Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation.

Edfeldt, K., Swedenborg, J., Hansson, G. K., & Yan, Z.-Q. (2002) · PubMed · Cited by 847 · see citing works

Expression of Toll-Like Receptors in Human Atherosclerotic Lesions

Edfeldt, K., Swedenborg, J., Hansson, G. K., & Yan, Z.-Q. (2002) · Circulation · doi:10.1161/circ.105.10.1158 · Cited by 706 · see citing works

Circulating Interleukin‐6 in Relation to Adiposity, Insulin Action, and Insulin Secretion

Vozarova, B., Weyer, C., Hanson, K. A., Tataranni, P. A., Bogardus, C., & Pratley, R. E. (2001) · Obesity Research · doi:10.1038/oby.2001.54 · Cited by 638 · see citing works

Plasma interleukin-6, tumour necrosis factor α and blood cytokine production in type 2 diabetes

Pickup, J. C., Chusney, G. D., Thomas, S. M., & Burt, D. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00622-6 · Cited by 566 · see citing works

Toll-like receptors as adjuvant receptors

Kaisho, T., & Akira, S. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(01)00182-3 · Cited by 493 · see citing works

The Lipopolysaccharide-activated Toll-like Receptor (TLR)-4 Induces Synthesis of the Closely Related Receptor TLR-2 in Adipocytes

Lin, Y., Lee, H., Berg, A. H., Lisanti, M. P., Shapiro, L. S., & Scherer, P. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002137200 · Cited by 355 · see citing works

An ancient system of host defense

Medzhitov, R., & Janeway, C. A. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80024-1 · Cited by 327 · see citing works

A Meta-analysis Comparing the Effect of Thiazolidinediones on Cardiovascular Risk Factors

Chiquette, E., Ramı́rez, G., & DeFronzo, R. A. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.19.2097 · Cited by 291 · see citing works

Resistin and Type 2 Diabetes: Regulation of Resistin Expression by Insulin and Rosiglitazone and the Effects of Recombinant Resistin on Lipid and Glucose Metabolism in Human Differentiated Adipocytes

McTernan, P. G., Fisher, F. M., Valsamakis, G., Chetty, R., Harte, A. L., McTernan, C. L., Clark, P. M. S., Smith, S. A., Barnett, A. H., & Kumar, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030898 · Cited by 279 · see citing works

Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood

Parker, T. S., Levine, D. M., Chang, J. C., Laxer, J., Coffin, C. C., & Rubin, A. L. (1995) · Infection and Immunity · doi:10.1128/iai.63.1.253-258.1995 · Cited by 211 · see citing works

Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia

Bauer, T. M., Schwacha, H., Steinbruckner, B., Brinkmann, F. E., Ditzen, A. K., Aponte, J. J., Pelz, K., Berger, D., Kist, M., & Blum, H. E. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05791.x · Cited by 211 · see citing works

Toll-like receptor family and signalling pathway

Muzio, M., Polentarutti, N., Bosisio, D., Kumar, P. P. M., & Mantovani, A. (2000) · Biochemical Society Transactions · doi:10.1042/bst0280563 · Cited by 187 · see citing works

Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development

Schoneveld, A. H., Nijhuis, M. M. O., VANMIDDELAAR, B., Laman, J. D., DEKLEIJN, D., & Pasterkamp, G. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.12.016 · Cited by 135 · see citing works

In vivo evidences that insulin regulates human polymorphonuclear neutrophil functions

Walrand, S., Guillet, C., Boirie‌, Y., & Vasson, M. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0104050 · Cited by 108 · see citing works

Gender differences in the regulation of P450 aromatase expression and activity in human adipose tissue

McTernan, P. G., Anwar, A., Eggo, M., Barnett, A. H., Stewart, P., & Kumar, S. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801254 · Cited by 106 · see citing works

Age-related changes in bone formation, osteoblastic cell proliferation, and differentiation during postnatal osteogenesis in human calvaria

de Pollak, C., Arnaud, É., Rénier, D., & Marie, P. J. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(199701)64:1 · Cited by 72 · see citing works

Monocytic expression of CD14 and CD18, circulating adhesion molecules and inflammatory markers in women with diabetes mellitus and impaired glucose tolerance

Fogelstrand, L., Hulthe, J., Hult�n, L., Wiklund, O., & Fagerberg, B. (2004) · Diabetologia · doi:10.1007/s00125-004-1553-x · Cited by 64 · see citing works

Eradication of small intestinal bacterial overgrowth and oro-cecal transit in diabetics.

Cuoco, L., Montalto, M., Jorizzo, R. A., Santarelli, L., Arancio, F., Cammarota, G., & Gasbarrini, A. (2002) · PubMed · Cited by 63 · see citing works

LPS induced release of IL-1β, IL-6, IL-8 and TNF-α in EDTA or heparin anticoagulated whole blood from persons with high or low levels of serum HDL

Eggesbø, J. B., Hjermann, I., Høstmark, A. T., & Kierulf, P. (1996) · Cytokine · doi:10.1006/cyto.1996.0022 · Cited by 43 · see citing works

Endogenous Gut-Derived Bacterial Endotoxin Tonically Primes Pancreatic Secretion of Insulin in Normal Rats

Cornell, R. P. (1985) · Diabetes · doi:10.2337/diab.34.12.1253 · Cited by 39 · see citing works

Inhibitory effects of hyperglycaemia on fed jejunal motility: potential role of hyperinsulinaemia

Byrne, Pluntke, Wank, Schirra, Arnol'd, �. �., Göke, & Katschinski (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.00240.x · Cited by 31 · see citing works

Insulin modulates rat intestinal glucose transport: effect of hypoinsulinemia and hyperinsulinemia

Westergaard, H. (1989) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1989.256.5.g911 · Cited by 25 · see citing works

Mechanisms of acute hyperinsulinemia after Kupffer cell phagocytosis

Cornell, R. P. (1980) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1980.238.3.e276 · Cited by 16 · see citing works

Modulation of hepatic reticuloendothelial system phagocytosis by pancreatic hormones.

Cornell, R., & Cc, M. (1982) · PubMed · Cited by 12 · see citing works

Functional interactions between the gut microbiota and host metabolism

Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387 · see citing works

Macrophages, inflammation, and insulin resistance

Olefsky, J. M., & Glass, C. K. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135846 · Cited by 2,733 · see citing works

The cellular and signaling networks linking the immune system and metabolism in disease

Osborn, O., & Olefsky, J. M. (2012) · Nature Medicine · doi:10.1038/nm.2627 · Cited by 1,551 · see citing works

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease

Miele, L., Valenza, V., La Torre, G., Montalto, M., Cammarota, G., Ricci, R., Mascianà, R., Forgione, A., Gabrieli, M. L., Perotti, G., et al. (2009) · Hepatology · doi:10.1002/hep.22848 · Cited by 1,434 · see citing works

Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples

Segata, N., Haake, S. K., Mannon, P., Lemon, K. P., Waldron, L., Gevers, D., Huttenhower, C., & Izard, J. (2012) · Genome Biology · doi:10.1186/gb-2012-13-6-r42 · Cited by 1,076 · see citing works

Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome

Maury, E., & Brichard, S. M. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.07.031 · Cited by 1,026 · see citing works

The role of the gut microbiota in energy metabolism and metabolic disease

Cani, P., & Delzenne, N. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788168164 · Cited by 974 · see citing works

Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling

Caesar, R., Tremaroli, V., Kovatcheva-Datchary, P., Cani, P. D., & Bäckhed, F. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.07.026 · Cited by 960 · see citing works

Inflammation and Lipid Signaling in the Etiology of Insulin Resistance

Glass, C. K., & Olefsky, J. M. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.001 · Cited by 942 · see citing works

Obesity, inflammation, and the gut microbiota

Cox, A. J., West, N. P., & Cripps, A. W. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70134-2 · Cited by 869 · see citing works

Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System

Postler, T. S., & Ghosh, S. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.05.008 · Cited by 876 · see citing works

The gut microbiota and obesity: from correlation to causality

Zhao, L. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3089 · Cited by 847 · see citing works

Linking Gut Microbiota and Inflammation to Obesity and Insulin Resistance

Saad, M. J. A., Santos, A., & Prada, P. O. (2016) · Physiology · doi:10.1152/physiol.00041.2015 · Cited by 818 · see citing works

Human Intestinal Barrier Function in Health and Disease

König, J., Wells, J. M., Cani, P. D., García‐Ródenas, C. L., MacDonald, T. T., Mercenier, A., Whyte, J., Troost, F. J., & Brummer, R. J. (2016) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2016.54 · Cited by 787 · see citing works

Targeting gut microbiota in obesity: effects of prebiotics and probiotics

Delzenne, N. M., Neyrinck, A. M., Bäckhed, F., & Cani, P. D. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.126 · Cited by 783 · see citing works

Intestinal Barrier Dysfunction, LPS Translocation, and Disease Development

Ghosh, S. S., Wang, J., Yannie, P. J., & Ghosh, S. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz039 · Cited by 780 · see citing works

Obesity and the human microbiome

Ley, R. E. (2009) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328333d751 · Cited by 768 · see citing works

Intestinal microbiota in patients with nonalcoholic fatty liver disease

Mouzaki, M., Comelli, E. M., Arendt, B. M., Bonengel, J., Fung, S. K., Fischer, S. E., McGilvray, I. D., & Allard, J. P. (2013) · Hepatology · doi:10.1002/hep.26319 · Cited by 749 · see citing works

Impact of Obesity and Metabolic Syndrome on Immunity

Andersen, C. J., Murphy, K. E., & Fernandez, M. L. (2016) · Advances in Nutrition · doi:10.3945/an.115.010207 · Cited by 701 · see citing works

Diet-Induced Dysbiosis of the Intestinal Microbiota and the Effects on Immunity and Disease

Brown, K., DeCoffe, D., Molcan, E., & Gibson, D. L. (2012) · Nutrients · doi:10.3390/nu4081095 · Cited by 682 · see citing works

Canonical Nlrp3 Inflammasome Links Systemic Low-Grade Inflammation to Functional Decline in Aging

Youm, Y.-H., Grant, R. W., McCabe, L. R., Albarado, D. C., Nguyen, K. Y., Ravussin, A., Pistell, P., Newman, S., Carter, R., Laque, A., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.09.010 · Cited by 674 · see citing works

Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia

Moreira, A. P. B., Teixeira, T. F. S., Machado, A. B. F., Pelúzio, M. D. C. G., & Alfenas, R. D. C. G. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512001213 · Cited by 653 · see citing works

Increased Gut Permeability and Microbiota Change Associate with Mesenteric Fat Inflammation and Metabolic Dysfunction in Diet-Induced Obese Mice

Lam, Y. Y., Ha, C. W. Y., Campbell, C. R., Mitchell, A. J., Dinudom, A., Oscarsson, J., Cook, D. I., Hunt, N. H., Caterson, I. D., Holmes, A. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034233 · Cited by 604 · see citing works

Gut Microbiota and Its Possible Relationship With Obesity

DiBaise, J. K., Zhang, H., Crowell, M. D., Krajmalnik‐Brown, R., Decker, G. A., & Rittmann, B. E. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.4.460 · Cited by 598 · see citing works

The gut microbiota, obesity and insulin resistance

Shen, J., Obin, M. S., & Zhao, L. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.11.001 · Cited by 599 · see citing works

Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation

Petra, A. I., Panagiotidou, S., Hatziagelaki, E., Stewart, J. M., Conti, P., & Theoharides, T. C. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.04.002 · Cited by 592 · see citing works

Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions

Mohammad, S., & Thiemermann, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594150 · Cited by 585 · see citing works

Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects

Dasu, M. R., Devaraj, S., Park, S., & Jialal, I. (2010) · Diabetes Care · doi:10.2337/dc09-1799 · Cited by 572 · see citing works

Diabetes, obesity and gut microbiota

Everard, A., & Cani, P. D. (2013) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2013.03.007 · Cited by 547 · see citing works

The role of adipose tissue immune cells in obesity and low-grade inflammation

Mraz, M., & Haluzik, M. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0283 · Cited by 543 · see citing works

Gut microbiota and metabolic syndrome

Festi, D., Schiumerini, R., Eusebi, L. H., Marasco, G., Taddia, M., & Colecchia, A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i43.16079 · Cited by 534 · see citing works

Gut microbiota and obesity

Gérard, P. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2061-5 · Cited by 512 · see citing works

Increase in Plasma Endotoxin Concentrations and the Expression of Toll-Like Receptors and Suppressor of Cytokine Signaling-3 in Mononuclear Cells After a High-Fat, High-Carbohydrate Meal

Ghanim, H., Abuaysheh, S., Sia, C. L., Korzeniewski, K., Chaudhuri, A., Fernandez-Real, J. M., & Dandona, P. (2009) · Diabetes Care · doi:10.2337/dc09-0979 · Cited by 494 · see citing works

The role of Gut Microbiota in the development of obesity and Diabetes

Baothman, O. A. S., Zamzami, M. A., Taher, I., Abubaker, J. A., & Abu‐Farha, M. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0278-4 · Cited by 493 · see citing works

Gut Microbiota, Lipopolysaccharides, and Innate Immunity in the Pathogenesis of Obesity and Cardiovascular Risk

Manco, M., Putignani, L., & Bottazzo, G. F. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0030 · Cited by 479 · see citing works

The Intestinal Barrier and Current Techniques for the Assessment of Gut Permeability

Schoultz, I., & Keita, Å. V. (2020) · Cells · doi:10.3390/cells9081909 · Cited by 479 · see citing works

Fight them or feed them: How the intestinal mucus layer manages the gut microbiota

Schroeder, B. O. (2019) · Gastroenterology report · doi:10.1093/gastro/goy052 · Cited by 464 · see citing works

Molecular Characterisation of the Faecal Microbiota in Patients with Type II Diabetes

Wu, X., Ma, C., Han, L., Nawaz, M., Gao, F., Zhang, X., Yu, P., Zhao, C., Li, L., Zhou, A., et al. (2010) · Current Microbiology · doi:10.1007/s00284-010-9582-9 · Cited by 461 · see citing works

The role of the gut microbiota in nonalcoholic fatty liver disease

Abu-Shanab, A., & Quigley, E. M. M. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.172 · Cited by 457 · see citing works

Assessing the Human Gut Microbiota in Metabolic Diseases

Karlsson, F. H., Tremaroli, V., Nielsen, J., & Bäckhed, F. (2013) · Diabetes · doi:10.2337/db13-0844 · Cited by 450 · see citing works

High Glucose Induces Toll-Like Receptor Expression in Human Monocytes

Dasu, M. R. K., Devaraj, S., Zhao, L., Hwang, D. H., & Jialal, I. (2008) · Diabetes · doi:10.2337/db08-0564 · Cited by 436 · see citing works

Metabolic endotoxemia with obesity: Is it real and is it relevant?

Boutagy, N. E., McMillan, R. P., Frisard, M. I., & Hulver, M. W. (2016) · Biochimie · doi:10.1016/j.biochi.2015.06.020 · Cited by 413 · see citing works

Endotoxemia Is Associated With an Increased Risk of Incident Diabetes

Pussinen, P. J., Havulinna, A. S., Lehto, M. J., Sundvall, J., & Salomaa, V. V. (2011) · Diabetes Care · doi:10.2337/dc10-1676 · Cited by 407 · see citing works

Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study

Eslamparast, T., Poustchi, H., Zamani, F., Sharafkhah, M., Malekzadeh, R., & Hekmatdoost, A. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.068890 · Cited by 406 · see citing works

You Are What You Eat—The Relationship between Diet, Microbiota, and Metabolic Disorders—A Review

Moszak, M., Szulińska, M., & Bogdański, P. (2020) · Nutrients · doi:10.3390/nu12041096 · Cited by 397 · see citing works

Elevated endotoxin levels in non-alcoholic fatty liver disease

Harte, A. L., da Silva, N. F., Creely, S. J., McGee, K. C., Billyard, T., Elabd, E. M. Y., Tripathi, G., Ashour, E., Abdalla, M. S., Sharada, H. M., et al. (2010) · Journal of Inflammation · doi:10.1186/1476-9255-7-15 · Cited by 389 · see citing works

Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer

Cani, P. D., & Jordan, B. F. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0025-6 · Cited by 383 · see citing works

Increased Toll-Like Receptor (TLR) 2 and TLR4 Expression in Monocytes from Patients with Type 1 Diabetes: Further Evidence of a Proinflammatory State

Devaraj, S., Dasu, M. R. K., Rockwood, J., Winter, W. E., Griffen, S. C., & Jialal, I. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2185 · Cited by 374 · see citing works

Gut microbiota, probiotics and diabetes

Gomes, A. C., Bueno, A. A., de Souza, R. G. M., & Mota, J. F. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-60 · Cited by 363 · see citing works

Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease

Miura, K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7381 · Cited by 355 · see citing works

Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes

Jayashree, B., Bibin, Y. S., Prabhu, D., Shanthirani, C. S., Gokulakrishnan, K., Lakshmi, B. S., Mohan, V., & Balasubramanyam, M. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1911-4 · Cited by 353 · see citing works

Adipose tissue-resident immune cells: key players in immunometabolism

Schipper, H. S., Prakken, B., Kalkhoven, E., & Boes, M. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2012.05.011 · Cited by 342 · see citing works

The gut microbiome as therapeutic target

Cani, P. D., & Delzenne, N. M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.012 · Cited by 349 · see citing works

Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder

Hoge, E. A., Brandstetter, K., Moshier, S., Pollack, M. H., Wong, K. K., & Simon, N. M. (2009) · Depression and Anxiety · doi:10.1002/da.20564 · Cited by 343 · see citing works

The western diet and lifestyle and diseases of civilization

Carrera-Bastos, P., Fontes, O'Keefe, Lindeberg, & Cordain (2011) · Research Reports in Clinical Cardiology · doi:10.2147/rrcc.s16919 · Cited by 342 · see citing works

Associations of the fecal microbiome with urinary estrogens and estrogen metabolites in postmenopausal women

Fuhrman, B. J., Feigelson, H. S., Flores, R., Gail, M. H., Xu, X., Ravel, J., & Goedert, J. J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2222 · Cited by 339 · see citing works

Metabolic endotoxemia and diabetes mellitus: A systematic review

Gomes, J. M. G., Costa, J. D. A., & Alfenas, R. D. C. G. (2016) · Metabolism · doi:10.1016/j.metabol.2016.12.009 · Cited by 334 · see citing works

Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat

Davis, J. E., Gabler, N. K., Walker‐Daniels, J., & Spurlock, M. E. (2008) · Obesity · doi:10.1038/oby.2008.210 · Cited by 334 · see citing works

Gut microflora as a target for energy and metabolic homeostasis

Cani, P. D., & Delzenne, N. M. (2007) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3282efdebb · Cited by 332 · see citing works

Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice

Caesar, R., Reigstad, C. S., Bäckhed, H. K., Reinhardt, C., Ketonen, M., Östergren‐Lundén, G., Cani, P. D., & Bäckhed, F. (2012) · Gut · doi:10.1136/gutjnl-2011-301689 · Cited by 330 · see citing works

Islet Inflammation Impairs the Pancreatic β-Cell in Type 2 Diabetes

Donath, M. Y., Böni‐Schnetzler, M., Ellingsgaard, H., & Ehses, J. A. (2009) · Physiology · doi:10.1152/physiol.00032.2009 · Cited by 327 · see citing works

The Human Gut Microbiome and Body Metabolism: Implications for Obesity and Diabetes

Devaraj, S., Hemarajata, P., & Versalovic, J. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.187617 · Cited by 321 · see citing works

Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability

de Punder, K., & Pruimboom, L. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00223 · Cited by 321 · see citing works

Macrophage functions in lean and obese adipose tissue

Thomas, D. D., & Apovian, C. M. (2017) · Metabolism · doi:10.1016/j.metabol.2017.04.005 · Cited by 318 · see citing works

The role of lipopolysaccharide-induced cell signalling in chronic inflammation

Page, M. J., Kell, D. B., & Pretorius, E. (2022) · Chronic Stress · doi:10.1177/24705470221076390 · Cited by 315 · see citing works

Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial

Laitinen, K., Poussa, T. A., Isolauri, E., & the Nutrition, A. (2008) · British Journal Of Nutrition · doi:10.1017/s0007114508111461 · Cited by 311 · see citing works

Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?

Diamant, M., Blaak, E. E., & de Vos, W. M. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00797.x · Cited by 308 · see citing works

Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials

Kellow, N. J., Coughlan, M. T., & Reid, C. M. (2014) · British Journal of Nutrition · doi:10.1017/s0007114513003607 · Cited by 307 · see citing works

The gut microbiota and metabolic disease: current understanding and future perspectives

Arora, T., & Bäckhed, F. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12508 · Cited by 301 · see citing works

Microbial Medicine: Prebiotic and Probiotic Functional Foods to Target Obesity and Metabolic Syndrome

Green, M., Arora, K., & Prakash, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082890 · Cited by 300 · see citing works

Gut Microbiome, Intestinal Permeability, and Tissue Bacteria in Metabolic Disease: Perpetrators or Bystanders?

Chakaroun, R., Massier, L., & Kovacs, P. L. (2020) · Nutrients · doi:10.3390/nu12041082 · Cited by 297 · see citing works

Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation

Laugerette, F., Vors, C., Géloën, A., Chauvin, M., Soulage, C. O., Lambert-Porcheron, S., Peretti, N., Alligier, M., Burcelin, R., Laville, M., et al. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.11.011 · Cited by 291 · see citing works

Toll-like Receptor Status in Obesity and Metabolic Syndrome: A Translational Perspective

Jialal, I., Kaur, H., & Devaraj, S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3092 · Cited by 286 · see citing works

The Intestinal Microbiota in Metabolic Disease

Woting, A., & Blaut, M. (2016) · Nutrients · doi:10.3390/nu8040202 · Cited by 284 · see citing works

Innate immunity and adipose tissue biology

Schäffler, A., & Schölmerich, J. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.03.001 · Cited by 283 · see citing works

Gut Microbiota, Bacterial Translocation, and Interactions with Diet: Pathophysiological Links between Major Depressive Disorder and Non-Communicable Medical Comorbidities

Slyepchenko, A., Maes, M., Jacka, F. N., Köhler, C. A., Barichello, T., McIntyre, R. S., Berk, M., Grande, I., Foster, J. A., Vieta, E., et al. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000448957 · Cited by 278 · see citing works

A Marker of Endotoxemia Is Associated With Obesity and Related Metabolic Disorders in Apparently Healthy Chinese

Sun, L. D., Yu, Z., Ye, X., Zou, S., Li, H., Yu, D., Wu, H., Chen, Y., Dore, J. M., Clément, K., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0340 · Cited by 277 · see citing works

Is the Gut Microbiota a New Factor Contributing to Obesity and Its Metabolic Disorders?

Harris, K. A., Kassis, A. N., Major, G. C., & Chou, C. J. (2012) · Journal of Obesity · doi:10.1155/2012/879151 · Cited by 274 · see citing works

The Role of Gut Microbiota on Insulin Resistance

Caricilli, A. M., & Saad, M. A. (2013) · Nutrients · doi:10.3390/nu5030829 · Cited by 273 · see citing works

Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases?

Brahe, L. K., Astrup, A., & Larsen, L. H. (2013) · Obesity Reviews · doi:10.1111/obr.12068 · Cited by 264 · see citing works

Adipokine inflammation and insulin resistance: the role of glucose, lipids and endotoxin

Piya, M. K., McTernan, P. G., & Kumar, S. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0498 · Cited by 262 · see citing works

Does lipopolysaccharide-mediated inflammation have a role in OA?

Huang, Z.-Y., & Kraus, V. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.158 · Cited by 259 · see citing works

Both systemic and local lipopolysaccharide (LPS) burden are associated with knee OA severity and inflammation

Huang, Z., Stäbler, T., Pei, F., & Kraus, V. B. (2016) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2016.05.008 · Cited by 264 · see citing works

Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties

Lecerf, J.-M., Dépeint, F., Clerc, E., Dugenet, Y., Niamba, C. N., Rhazi, L., Cayzeele, A., Abdelnour, G., Jaruga, A., Younes, H., et al. (2012) · British Journal of Nutrition · doi:10.1017/s0007114511007252 · Cited by 262 · see citing works

Role of the Gut Microbiome in Obesity and Diabetes Mellitus

Barlow, G. M., Yu, A. T., & Mathur, R. (2015) · Nutrition in Clinical Practice · doi:10.1177/0884533615609896 · Cited by 261 · see citing works

Microbial modulation of insulin sensitivity

Khan, M. T., Nieuwdorp, M., & Bäckhed, F. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.07.006 · Cited by 260 · see citing works

Hyperinsulinemia: An Early Indicator of Metabolic Dysfunction

Thomas, D. D., Corkey, B. E., Istfan, N. W., & Apovian, C. M. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00065 · Cited by 261 · see citing works

Dietary fucoidan improves metabolic syndrome in association with increased Akkermansia population in the gut microbiota of high-fat diet-fed mice

Shang, Q., Song, G., Zhang, M., Shi, J., Xu, C., Hao, J., Li, G., & Yu, G. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2016.11.002 · Cited by 258 · see citing works

Disruption of the Circadian Clock in Mice Increases Intestinal Permeability and Promotes Alcohol-Induced Hepatic Pathology and Inflammation

Summa, K. C., Voigt, R. M., Forsyth, C. B., Shaikh, M. W., Cavanaugh, K. E., Tang, Y., Vitaterna, M. H., Song, S., Turek, F. W., & Keshavarzian, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067102 · Cited by 254 · see citing works

Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism

Caesar, R., Fåk, F., & Bäckhed, F. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02270.x · Cited by 253 · see citing works

Metabolic stress-induced joint inflammation and osteoarthritis

Courties, A., Gualillo, O., Berenbaum, F., & Sellam, J. (2015) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2015.05.016 · Cited by 249 · see citing works

TLR4 and Insulin Resistance

Kim, J. J., & Sears, D. D. (2010) · Gastroenterology Research and Practice · doi:10.1155/2010/212563 · Cited by 249 · see citing works

Hepatic TLR4 signaling in obese NAFLD

Sharifnia, T., Antoun, J., Verriere, T. G., Suárez, G., Wattacheril, J. J., Wilson, K. T., Peek, R. M., Abumrad, N. N., & Flynn, C. R. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00304.2014 · Cited by 247 · see citing works

Pregravid Obesity Associates With Increased Maternal Endotoxemia and Metabolic Inflammation

Basu, S., Haghiac, M., Surace, P., Challier, J.-C., Guerre-Millo, M., Singh, K., Waters, T. P., Minium, J., Presley, L. H., Catalano, P. M., et al. (2010) · Obesity · doi:10.1038/oby.2010.215 · Cited by 246 · see citing works

Differential Effects of Cream, Glucose, and Orange Juice on Inflammation, Endotoxin, and the Expression of Toll-Like Receptor-4 and Suppressor of Cytokine Signaling-3

Deopurkar, R., Ghanim, H., Friedman, J., Abuaysheh, S., Sia, C. L., Mohanty, P., Viswanathan, P., Chaudhuri, A., & Dandona, P. (2010) · Diabetes Care · doi:10.2337/dc09-1630 · Cited by 246 · see citing works

Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs

Schäffler, A., Schölmerich, J., & Salzberger, B. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.07.003 · Cited by 244 · see citing works

High Fat Intake Leads to Acute Postprandial Exposure to Circulating Endotoxin in Type 2 Diabetic Subjects

Harte, A. L., Varma, M. C., Tripathi, G., McGee, K. C., Al‐Daghri, N. M., Al-Attas, O. S., Sabico, S., O’Hare, J. P., Ceriello, A., Saravanan, P., et al. (2011) · Diabetes Care · doi:10.2337/dc11-1593 · Cited by 236 · see citing works

Leaky gut and diabetes mellitus: what is the link?

de Kort, S., Keszthelyi, D., & Masclee, A. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00845.x · Cited by 233 · see citing works

Diabetes and Nonalcoholic Fatty Liver Disease: A Pathogenic Duo

Williams, K., Shackel, N. A., Gorrell, M. D., McLennan, S. V., & Twigg, S. M. (2012) · Endocrine Reviews · doi:10.1210/er.2012-1009 · Cited by 232 · see citing works

Determining the mechanism contributing to sub-clinical inflammation in metabolic disease

Creely, S. J. (2026) · OpenGrey (Institut de l'Information Scientifique et Technique) · doi:10.82444/warw.33489676

Altered Subcutaneous Adipose Tissue Response to Systemic LPS Administration in Patients with Type 2 Diabetes

Mathur, N. (2012) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000217 · Cited by 1 · see citing works

Innate Immunity in Type 2 Diabetes Pathogenesis: Role of the Lipopolysaccharide Signaling Cascade: A Dissertation

Young, J. L. (2008) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/4kma-sa11

Inducible Toll‐like Receptor and NF‐κB Regulatory Pathway Expression in Human Adipose Tissue

Vitseva, O. I., Tanrıverdi, K., Tchkonia, T., Kirkland, J. L., McDonnell, M. E., Apovian, C. M., Freedman, J. E., & Gokce, N. (2008) · Obesity · doi:10.1038/oby.2008.25 · Cited by 215 · see citing works

Stimulation with Peptidoglycan induces interleukin 6 and TLR2 expression and a concomitant downregulation of expression of adiponectin receptors 1 and 2 in 3T3-L1 adipocytes

Ajuwon, K. M., Banz, W. J., & Winters, T. A. (2009) · Journal of Inflammation · doi:10.1186/1476-9255-6-8 · Cited by 48 · see citing works